About
About Shin Nippon Biomedical Laboratories, Ltd
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Visit company website
5 years, 5 months ago
Shin Nippon Biomedical Laboratories, Ltd is currently in a long term uptrend where the price is trading 42.5% above its 200 day moving average.
From a valuation standpoint, the stock is 97.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Shin Nippon Biomedical Laboratories, Ltd's total revenue sank by 7.2% to $3B since the same quarter in the previous year.
Its net income has dropped by 53.7% to $337M since the same quarter in the previous year.
Based on the above factors, Shin Nippon Biomedical Laboratories, Ltd gets an overall score of 2/5.